|
|
Targeting Hyaluronan Interactions for Glioblastoma Stem Cell TherapyDOI: 10.1007/s12307-019-00224-2 Keywords: Glioblastoma (GBM), Hyaluronic acid (HA), Tumor microenvironment, Temozolomide (TMZ), Combination therapy Abstract: The online version of this article (10.1007/s12307-019-00224-2) contains supplementary material, which is available to authorized users
|
